Active surveillance for T1bN0M0 papillary thyroid carcinoma

T Sakai, I Sugitani, A Ebina, O Fukuoka, K Toda… - Thyroid, 2019 - liebertpub.com
Background: Prospective trials of active surveillance for asymptomatic papillary
microcarcinoma (T1aN0M0) since the 1990s have shown progression rates of only 5–10 …
被引用次数：169 相关文章

[引用][C] Active Surveillance for T1bN0M0 Papillary Thyroid Carcinoma

T Sakai, I Sugitani, A Ebina, O Fukuoka, K Toda… - Thyroid, 2019 - cir.nii.ac.jp
Active Surveillance for T1bN0M0 Papillary Thyroid Carcinoma | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …

Active Surveillance for T1bN0M0 Papillary Thyroid Carcinoma.

T Sakai, I Sugitani, A Ebina, O Fukuoka, K Toda… - …, 2019 - search.ebscohost.com
Background: Prospective trials of active surveillance for asymptomatic papillary
microcarcinoma (T1aN0M0) since the 1990s have shown progression rates of only 5–10 …

Active Surveillance for T1bN0M0 Papillary Thyroid Carcinoma.

T Sakai, I Sugitani, A Ebina, O Fukuoka… - … : Official Journal of the …, 2019 - europepmc.org
Background Prospective trials of active surveillance for asymptomatic papillary
microcarcinoma (T1aN0M0) since the 1990s have shown progression rates of only 5-10 …

Active Surveillance for T1bN0M0 Papillary Thyroid Carcinoma

T Sakai, I Sugitani, A Ebina… - … : official journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Prospective trials of active surveillance for asymptomatic papillary
microcarcinoma (T1aN0M0) since the 1990s have shown progression rates of only 5-10 …